is glutathione a tyrosinase inhibitor comprehensive review on inhibitors In silico and in vitro

Read the full BPC-157 clinical overview BPC-157 vs TB-500: Comparison Side-by-side comparison of two leading healing peptides: mechanisms, indications, and how they are used together

Gastric ulcer protection: BPC-157s original characterization was as an anti-ulcer peptide, and its gastroprotective effects against alcohol, capsaicin, stress-induced, and NSAID-induced gastric lesions have been demonstrated across numerous published studies

2020 Mar;6(2):284-287

Metabolite profiling reveals that the most frequently-occurred BRAF mutation endows melanoma cells with enhanced glycolytic capacity, which can be attributed to the upregulation of a network of transcriptional factors, glucose transporters, and kinases controlling glycolysis including HIF1, MYC, Glut 1, Glut 3, and Hexokinase 2 (HK2)